The Innergetic Movement

10/04/2026

Obvious isn’t it?

03/04/2026

The video presents the perspective of Alan Watts on psychedelics—not as recreational drugs, but as tools for expanding consciousness.

His central idea:

Psychedelics can temporarily dissolve the illusion of the separate self and reveal a deeper unity with reality.

⸻

🔑 Key Themes

1. Psychedelics as “Consciousness Amplifiers”

They don’t “add” anything new. They reveal what’s already there, but normally filtered out by the brain. Think of them as turning up the volume on perception and awareness.

2. The Illusion of the Ego. Watts emphasizes that our sense of being a separate, isolated self is largely an illusion.
Psychedelics can dissolve this boundary, leading to: Ego dissolution. Feeling “at one” with everything. This aligns with Eastern philosophies (e.g. Buddhism, Vedanta).

3. Unity & Interconnectedness A major insight reported: Everything is deeply interconnected. The distinction between “you” and “the universe” collapses. This can feel profoundly meaningful or even spiritual.

⸻

4. The Problem with Over-Attachment. Watts warns: People may chase the experience instead of integrating it. His famous analogy:

“When you get the message, hang up the phone.” Meaning: Psychedelics are a tool, not something to rely on continuously.

⸻

5. Cultural Misunderstanding. Society often labels psychedelics as dangerous or purely recreational. Watts argues: The real issue is misuse, not the substances themselves. In the right context, they can be deeply insightful.

⸻

6. Direct Experience vs Belief. Psychedelics can provide: Direct experiential insight (not just intellectual understanding). This is different from: Reading books. Hearing teachings. It’s more like “seeing for yourself”.

⸻

7. Integration is Everything. The experience itself is not the end goal. What matters is: How you apply the insight afterward. Without integration: The experience can become meaningless or even destabilising.

⸻

⚖️ Underlying Philosophy

Watts is essentially saying:
• Psychedelics can point to truth, but they are not the truth themselves.
• They are like a doorway, not a destination.

⸻

🧩 In Simple Terms
• Psychedelics = a temporary shift in perception
• That shift = reveals deeper truths about self and reality
• But growth = comes from what you do after

Psychedelics are among the most misunderstood substances in modern culture. To some, they are dismissed as dangerous drugs. To Alan Watts, they are far more ...

02/04/2026

Throwback. A fun podcast 😊

Nick Te***ne has been a hypnotherapist specialising in smoking for over 15 years and has helped over 5,000 people in quitting smoking and va**ng permanently....

28/03/2026

Here’s what Google AI had to say about this book and the idea that Jesus and his disciples engaged in the ritualistic use of psilocybin which we know can induce a mystical experience.

You be the judge 🤔

*************

The idea of a "psychedelic Gospel" is a controversial theory proposed in various books and academic discussions, most notably in the work The Psychedelic Gospels: The Secret History of Hallucinogens in Christianity by Jerry B. and Julie M. Brown.

Key Concepts:

Theories of Entheogenic Use: Proponents of this theory argue that psychoactive plants and fungi (entheogens) were used in early and medieval Christian rituals to induce mystical, visionary experiences, and that these were the true "sacraments".

Iconographic Evidence: The primary evidence cited often comes from interpretations of religious art, such as frescoes, mosaics, and illuminated manuscripts, that appear to depict Amanita muscaria or psilocybin-containing mushrooms. A prominent example is a 12th-century fresco in the Chapel of Plaincourault, France, which shows a "mushroom tree" in the Garden of Eden scene.

Scriptural Interpretation: Authors like the Browns and John M. Allegro reinterpret biblical narratives and the Gnostic Gospels, suggesting that concepts like the "Tree of Knowledge" in Eden or the "manna" that fed the Israelites were metaphors for sacred mushrooms or ergot-spiked bread.

Suppression of Information: A central tenet of the theory is that the use of psychedelics was a "secret history" suppressed by Church authorities, possibly in a deliberate effort to consolidate power and control the spiritual narrative.

Connection to Paganism: The theories suggest a continuity from ancient Greek Eleusinian Mysteries, which possibly used ergot-spiked kykeon (a psychoactive brew), to early Christian practices.

Scholarly Reception. The theory is considered highly controversial and generally not accepted by mainstream biblical or medieval scholars.

Lack of Concrete Evidence: Critics argue that the evidence is circumstantial and speculative, relying heavily on subjective interpretations of art and linguistics.

Alternative Explanations: Art historians and other scholars often provide alternative, non-entheogenic explanations for the artistic depictions.

Modern Agenda: Some researchers suggest that the persistent interest in linking Christianity to psychedelics is more reflective of the modern psychedelic renaissance and a desire for historical legitimacy for contemporary use, rather than a factual historical account.

Historical Condemnation: The Church actively condemned ecstatic states and Gnostic practices, which many scholars see as evidence that such practices were outside the orthodox tradition, not a "secret" part of it.

In summary, the "psychedelic Gospel" is a provocative but largely academic and popular debate, not a widely accepted historical fact within the established scholarly community.

21/03/2026

Australia became the first country in the world to formally authorize psilocybin as a prescribed therapeutic in 2023 — and by 2025, the clinical data from the first two years of regulated therapeutic use has arrived, confirming outcomes that exceed those of any other psychiatric treatment for PTSD and treatment-resistant depression ever studied. The results have triggered a cascade of regulatory reconsiderations in the UK, Canada, and across the EU, with researchers at the University of Melbourne's Centre for Mental Health leading the charge in publishing the definitive real-world outcomes data.

Psilocybin — the active compound in certain mushrooms — produces its therapeutic effects through profound but temporary alteration of the brain's default mode network: the self-referential neural circuit associated with rumination, negative self-narrative, and the "locked-in" thought patterns that characterize PTSD and treatment-resistant depression. For 4-6 hours, the rigid self-model dissolves. Patients access emotional content and perspectives ordinarily barricaded by psychological defense mechanisms. With skilled therapeutic support, this window enables processing of traumatic memories that years of conventional therapy failed to reach.

In Melbourne's 400-patient real-world outcomes study — covering the first two years of legal therapeutic use — 72% of PTSD patients and 68% of treatment-resistant depression patients achieved clinical response. At 12-month follow-up, 58% remained symptom-free with no additional treatment. Adverse event rates were low when administered in structured therapeutic settings. 🍄

Australia regulated what the world was doing underground for decades. The data has validated that decision entirely.

Source: University of Melbourne Centre for Mental Health, The Lancet Psychiatry, 2025

16/03/2026

Which of these 11 hit you the hardest? Like and share this kind of thing and your facebook feed will start to be a more positive one 😊

13/03/2026

Helpful not brutal 🤔

12/03/2026

Be mindful who and what you stand for 🤔

11/03/2026

For those who also feel a connection to ancient Egypt. An audio-visual delight 😊

What if Ancient Egypt never fell, but evolved into the ultimate global superpower?EGYPT: The Golden Pharaoh's Black Obsidian Empire is a visual odyssey into ...

11/03/2026

Dam! How cool is this?!

✨ Welcome to The Dream Metropolis!Immerse yourself in Golden Future ✦This 1-hour luxury sci-fi ambient experience is a compilation of 10 futuristic cities, e...

09/03/2026

In 1962, a Harvard student gave theology students psychedelic mushrooms in a chapel.

His paper, “Drugs and Mysticism,” published in the International Journal of Parapsychology, laid out what would become one of the most discussed and debated studies in the history of psychedelic research.

Walter N. Pahnke was a trained physician, a theologian, and someone deeply serious about consciousness.

He built a nine-category framework for mystical experience, then asked: can a molecule reliably trigger what saints spent lifetimes chasing?

Eight of ten who took psilocybin had full mystical experiences. Zero in the placebo group did.

Six months later, those who had taken psilocybin reported lasting positive changes in their relationship to themselves, to others, and to the meaning of their lives.

The experimenter noted that eight out of ten subjects seemed profoundly changed.

Critics say chemically induced transcendence is cheating. Pahnke disagreed. The experience opens the door, he said. What you do with it is what counts.

He wrote: “Perhaps the hardest ‘work’ comes after the experience, which in itself may only provide the motivation for future efforts to integrate and appreciate what has been learned.”

The uncomfortable truth is these states - of unity, awe, and contact with something vast - appear in every culture in history. They're human, but we've built a civilisation with almost no legitimate way to access them.

They may not be proof of God, but they are evidence that there’s more to life than many of us realise.

07/03/2026

A new clinical trial studied how a single D.M.T session affected people with moderate to severe depression who had already tried other treatments.

The research was conducted by scientists at Imperial College London together with the biotechnology company Cybin Inc..

In the first part of the study, 34 participants were randomly assigned to receive either the treatment or a placebo infusion. Two weeks later, researchers reported that people who received D.M.T showed a larger drop in depression scores compared with the placebo group.

What surprised researchers was how quickly changes appeared. Some participants showed improvement within one week.

After the controlled phase, all participants were given access to the active treatment. Many maintained improvements for up to three months during follow-up checks.

Reported side effects were generally mild and short-lasting, including nausea, temporary anxiety, and discomfort at the infusion site.

Researchers say larger studies are still needed to better understand long-term safety and effectiveness.

Source: Erritzoe D. et al., “D.M.T assisted therapy for major depressive disorder,” Nature Medicine, 2024.

➡️ Note: This content is shared for academic interest, based on scientific studies and historical records. It does not promote, sell, or encourage recreational or non-medical substance use.

.M.TResearch